Description

1,4-Epoxy-1H,3H-(1,4)Oxazepino(4,3-A)Benzimidazole, 4,5-Dihydro-1-(2-Chlorophenyl)- is a high-purity, advanced pharmaceutical intermediate characterized by its complex heterocyclic structure. This compound is of significant value for its role as a key building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring sophisticated molecular architectures. It is primarily sought after by research institutions and manufacturers in the pharmaceutical and fine chemical industries engaged in drug discovery and process development.

Application

• Pharmaceutical Intermediate: A critical precursor in the multi-step synthesis of proprietary drug candidates and novel therapeutic agents.
• Organic Synthesis Research: Serves as a versatile scaffold for medicinal chemists exploring new chemical entities and structure-activity relationships.
• API Development: Used in the research and development phase for creating new Active Pharmaceutical Ingredients, especially in central nervous system (CNS) or oncology-related research.
• Fine Chemical Production: Employed in the manufacture of complex, high-value specialty chemicals for advanced applications.
• Contract Research & Manufacturing (CRAM): Supplied to organizations offering custom synthesis and process scale-up services.

Basic Information

Item	Details
Product Name	1,4-Epoxy-1H,3H-(1,4)Oxazepino(4,3-A)Benzimidazole, 4,5-Dihydro-1-(2-Chlorophenyl)-
CAS No.	76099-05-3
Molecular Formula	C₁₇H₁₁ClN₂O₂
Molecular Weight	310.73 g/mol
Synonyms	1-(2-Chlorophenyl)-4,5-dihydro-1H,3H-[1,4]oxazepino[4,3-a]benzimidazole-1,4-diol 1,4-epoxide; 1-(2-Chlorophenyl)-4,5-dihydro-1H,3H-[1,4]oxazepino[4,3-a]benzimidazole-1,4-epoxide; 1-(2-Chlorophenyl)-4,5-dihydro-1H,3H-oxazepino[4,3-a]benzimidazole-1,4-epoxide; 76099-05-3; (1,4)Oxazepino(4,3-A)Benzimidazole, 1,4-Epoxy-1H,3H-, 4,5-Dihydro-1-(2-Chlorophenyl)-; 1-(2-Chlorophenyl)-4,5-dihydro-1H,3H-[1,4]oxazepino[4,3-a]benzimidazole 1,4-dioxide (related oxide form).
EINECS	Contact for details

Quality Control

Our production of 1,4-Epoxy-1H,3H-(1,4)Oxazepino(4,3-A)Benzimidazole, 4,5-Dihydro-1-(2-Chlorophenyl)- adheres to stringent quality protocols suitable for pharmaceutical R&D applications. Each batch undergoes rigorous analytical testing to ensure identity, purity, and consistency. A comprehensive Certificate of Analysis (COA) detailing purity by HPLC, related substances, and other critical parameters is provided with every shipment to support your quality and regulatory requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (typically 15-25°C). This compound should be handled as a moisture-sensitive material and kept under an inert atmosphere for long-term storage to ensure stability.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.